list of glp 1 agonists current GLP-1 and its analogs [36-39] List of approved and pending

(5) Fc fusion

These agents mimic the action of endogenous GLP-1, an incretin hormone released from intestinal L-cells in response to nutrient intake

Food and Drug Administration (FDA), the approved dosages for some of the commonly prescribed GLP-1 agonists are as follows: Semaglutide (Ozempic): 0.5 mg, 1 mg, or 2 mg once weekly for type 2 diabetes, and up to 2.4 mg once weekly for chronic weight management (marketed as Wegovy)

Clinical Trial Results SURMOUNT-1 trial: Average weight loss of ~20% of total body weight

A doctor or other trusted healthcare professional can help determine whether a GLP-1 agonist may be beneficial for you, depending on your health concerns and goals

Download Summary Sheet Here